tirzepatide vision problems #Mounjaro & eyesight…. 2025 reality. The “blindness” stories are mostly about NAION (an eye-stroke). A large study found a very small increase (0.04% vs 0.02%) in people on #semaglutide / #tirzepatide GLP-1s and Eye Health: What

The medication works by slowing gastric emptying, enhancing insulin secretion in a glucose-dependent manner, and reducing appetite through central nervous system pathways

Side effects were reportedly similar to GLP-1 medications, most commonly including gastrointestinal complications like nausea, vomiting and diarrhea

7072 In a recent RCT, retatrutide, a potent GLP-1RA agonist in late-stage development, eliminated 86% of fat from the liver in patients with MASLD (Fig

Re-suspend the cell precipitate in RPMI-1640 complete medium containing M-CSF for further culture

Trinh H, Donovan A, McAdam-Marx C (2025) Real-world effectiveness of Tirzepatide versus semaglutide for weight loss in overweight or obese patients in an ambulatory care setting

They have no incentive to fast-track things that work. The competing forces working to expand and limit the reach of BPC-157 highlight the strange tension that defines the wellness and biohacking spaces in 2026